Related Experiment Video

Updated: Aug 11, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Long-term outcome after primary stenting versus balloon angioplasty for acute myocardial infarction

Hisataka Sasao1, Kazufumi Tsuchihashi, Kazuhiko Nagao

  • 1Department of Cardiology, Sapporo Social Insurance General Hospital, Sapporo, Hokkaido, Japan.

International Heart Journal
|February 16, 2006
PubMed

Insights

Primary stenting significantly improves long-term outcomes for acute myocardial infarction patients compared to balloon angioplasty alone. This study shows stenting reduces major adverse events over five years, offering a better clinical result.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • Acute myocardial infarction (AMI) management aims to restore blood flow and improve patient outcomes.
  • Primary percutaneous transluminal coronary angioplasty (PTCA) is a common treatment for AMI.
  • The role of stenting versus balloon angioplasty alone in long-term AMI outcomes requires further investigation.

Purpose of the Study:

  • To compare the 5-year clinical outcomes of primary stenting versus primary balloon angioplasty without stenting (POBA) in patients with AMI.
  • To evaluate the long-term efficacy and safety of primary stenting in AMI treatment.

Main Methods:

  • Prospective, multicenter case-control study conducted at 7 cardiovascular centers in Hokkaido, Japan.
  • Analysis of 41 patients treated with successful primary stenting (stent group) and 41 matched controls treated with successful primary PTCA without stenting (POBA group).
  • Clinical endpoints assessed included death, heart failure, myocardial infarction, repeat revascularization, and cerebrovascular events over 5 years.

Main Results:

  • After 1 year, the stent group showed a significantly lower incidence of combined clinical endpoints (17.1% vs. 39.0%, P=0.049).
  • After 5 years, the stent group continued to demonstrate a lower combined endpoint incidence (34.1% vs. 61.0%, P=0.027), despite similar rates of heart failure and cardiac death.
  • Kaplan-Meier analysis revealed significantly lower event-free survival in the stent group (P=0.0116).
  • Logistic regression identified age ≥ 69 and stenting as significant factors influencing clinical events.

Conclusions:

  • Primary stenting for acute myocardial infarction leads to better long-term clinical outcomes compared to primary balloon angioplasty without stenting.
  • Stenting is associated with a reduced risk of major adverse cardiovascular events in AMI patients over a 5-year follow-up period.
  • Age is a significant predictor of adverse events in AMI patients undergoing revascularization.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...